Who Owns Avalo Therapeutics Stock?
NASDAQ: AVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 126.38%
- Institutions (% of float)
- 128.40%
- Held by insiders
- 1.57%
- Institutional holders
- 200
- Institutions 98.4%
- Insiders 1.6%
- Public and other 0.0%
Who owns Avalo Therapeutics stock?
Institutional investors own about 126.4% of Avalo Therapeutics's shares, spread across 200 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.57% of AVTX.
The largest institutional holders are FMR, LLC (9.08%), Blackrock Inc. (8.58%) and Farallon Capital Management LLC (6.87%). Together, the top 10 institutions control 59.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their AVTX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AVTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 5.25M | 9.08% | +2.9% |
| Blackrock Inc. | 4.96M | 8.58% | +13.6% |
| Farallon Capital Management LLC | 3.97M | 6.87% | +59.1% |
| Deep Track Capital, Lp | 3.61M | 6.24% | 0.0% |
| Caligan Partners, LP | 3.27M | 5.65% | +3.3% |
| Affinity Asset Advisors, Llc | 3.24M | 5.61% | +11.9% |
| TCG Crossover Management, LLC | 3.02M | 5.22% | 0.0% |
| State Street Corporation | 2.56M | 4.43% | -11.3% |
| Avoro Capital Advisors LLC | 2.38M | 4.11% | +1.9% |
| Vanguard Capital Management LLC | 2.26M | 3.90% | -0.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AVTX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.68M | 2.90% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.47M | 2.54% |
| iShares Trust-iShares Russell 2000 ETF | 1.32M | 2.28% |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 1.29M | 2.22% |
| Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund | 648.30K | 1.12% |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 582.36K | 1.01% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 537.24K | 0.93% |
| T. Rowe Price Health Sciences Fund, Inc. | 471.82K | 0.82% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 457.31K | 0.79% |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 424.95K | 0.73% |
Frequently asked questions
Who is the largest shareholder of Avalo Therapeutics?
FMR, LLC is the largest institutional shareholder of AVTX, owning 9.08% of shares outstanding (5.25M shares) as of its latest 13F filing.
What percentage of Avalo Therapeutics is owned by institutions?
Institutions own about 126.4% of AVTX shares and 128.4% of the public float.
How much of Avalo Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.57% of AVTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.